UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004880
Receipt number R000005810
Scientific Title Clinical Research; Efficacy of human atrial natriuretic peptide (hANP) on lung cancer surgery Basic Research; Efficacy of hANP on lung cancer
Date of disclosure of the study information 2011/05/18
Last modified on 2015/04/28 16:19:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Research; Efficacy of human atrial natriuretic peptide (hANP) on lung cancer surgery
Basic Research; Efficacy of hANP on lung cancer

Acronym

hANP study of lung cancer

Scientific Title

Clinical Research; Efficacy of human atrial natriuretic peptide (hANP) on lung cancer surgery
Basic Research; Efficacy of hANP on lung cancer

Scientific Title:Acronym

hANP study of lung cancer

Region

Japan


Condition

Condition

lung cancer

Classification by specialty

Pneumology Chest surgery

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

The objective of this study is to evaluate the efficacy of hANP on lung cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II,III


Assessment

Primary outcomes

1.The early reccurence of lung cancer after pulmonary resection
2.The incidence of postoperative complications after lung cancer surgery

Key secondary outcomes

1.Postoperative hemodynamics
2.Postoperative inflammatory change (white blood cell count and C-reactive protein level)
3.Postoperative creatinine levels and glomerular filtration rate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Group of hANP treatment

Interventions/Control_2

Control group

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

All patients undergoing pulmonary resection for lung cancer in our hospital

Key exclusion criteria

None

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takashi Nojiri

Organization

Osaka University Graduate School of Medicine

Division name

General Thoracic Surgery

Zip code


Address

2-2 (L5), Yamadaoka, Suita-City, Osaka 565-0871, Japan

TEL

06-6879-3152

Email

nojiri@ri.ncvc.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takashi Nojiri

Organization

National Cerebral and Cardiovascular Center

Division name

Biochemistry

Zip code


Address

5-7-1, Fujishirodai, Suita-City, Osaka 565-8565

TEL

06-6833-5012

Homepage URL


Email

nojiri@ri.ncvc.go.jp


Sponsor or person

Institute

Department of General Thoracic Surgery, Osaka University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

National Cerebral and Cardiovascular Center
National Toneyama Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学附属病院(大阪府)
国立循環器病研究センター(大阪府)
国立病院機構刀根山病院(大阪府)


Other administrative information

Date of disclosure of the study information

2011 Year 05 Month 18 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2007 Year 08 Month 01 Day

Last follow-up date

2012 Year 07 Month 31 Day

Date of closure to data entry

2012 Year 07 Month 31 Day

Date trial data considered complete

2012 Year 07 Month 31 Day

Date analysis concluded

2014 Year 07 Month 31 Day


Other

Other related information



Management information

Registered date

2011 Year 01 Month 14 Day

Last modified on

2015 Year 04 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005810


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name